浅析消痔灵注射液治疗痔疮的安全性风险

摘要

By reviewing the relevant references and reports of the adverse drug reaction cases of Xiaozhiling in China,rnand analyzing the post marketing safety studies, the safety and risks in post-marketing period of Xiaozhiling is rnreevaluated in this article. The author puts forward risk management measures according to the characteristics of rnmedicine. Suggestions are proposed for a safe and rational use of this medicine.%通过对消痔灵注射液安全性相关的国内文献报道、安全性研究状况进行分析,评价消痔灵注射液上市后的安全性情况及风险特点,提出符合药品本身特点的风险控制措施,为安全、合理使用该药提供建议.